Cyprotex Highlights - June 2020
Our US site in Watertown has been awarded a new 5 year contract with the US Environmental Protection Agency (EPA) worth up to US $13 million.
This project is part of the EPA’s Computational Toxicology and Exposure Research (CompTox) efforts and aims to provide a solutions-driven approach to evaluate the potential human and environmental health risks caused by environmental chemical exposure.
Our latest blog delves into the exciting work recently published in the International Journal of Molecular Sciences. The project studies the effect of thyroid hormone synthesis disruptors on human health and is funded by the European Unions’s Horizon 2020 research and innovation program.
Our Modelling and Simulation (M&S) group at Cyprotex have contributed towards the prediction of in vivo health outcomes by means of a computational simulation model.
Click on the link below to find out more.
This month, we are delighted to launch our latest service, the cell stress panel assay.
The assay is made up of 36 biomarkers representing several key cellular stress mechanisms, including mitochondrial toxicity, gene regulation and inflammation, measured primarily using high content imaging. The panel can be used to identify potential chemical liabilities when conducting non-animal safety assessments.
Click on the links below to find out more or to make an enquiry.
Read the latest news from parent company, Evotec:
- Just – Evotec Biologics enters into agreement with Advanced BioScience Laboratories, Inc. to develop broadly neutralising antibody against HIV
- Evotec, Samsara BioCapital and KCK Ltd launch Autobahn Labs, a novel early stage drug discovery incubator
- New webinar: How to win the war of attrition
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
enquiries@cyprotex.com